Search Login Register

Vision Disorders (Hemeralopia) Summary

102 relevant articles (8 outcomes, 4 trials/studies) found for this Disease

Description: Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions. Visual disability refers to inability of the individual to perform specific visual tasks, such as reading, writing, orientation, or traveling unaided. (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132)

Also Known As: Hemeralopia; Micropsia; Metamorphopsia; Macropsia; Day Blindness Show All >>

Key Drugs and Agents for Vision Disorders

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Retinaldehyde (Retinal) : 1 outcome 2 studies in 20 results : IBA
  2. Fluorescein (Funduscein) : 1 outcome in 8 results : FDA 2
  3. Cellophane : 1 outcome in 2 results : IBA
  4. Argon : 1 outcome in 2 results : IBA
  5. verteporfin (Visudyne) : 1 outcome in 1 result : FDA 1
  6. Carbon Monoxide : 1 study in 3 results : IBA
  7. 1-(1-phenylcyclohexyl)pyrrolidine (PHP) : 3 results : IBA
  8. 1-phenyl-3,3-dimethyltriazene (PDT) : 3 results : IBA
  9. Sympathomimetics (Sympathomimetic Amines) : 2 results : IBA
  10. Streptomycin (Streptomycin Sulfate) : 2 results : FDA 7
Show All >>

Diseases Related to Vision Disorders

  1. Diplopia (Double Vision)
  2. Syndrome
  3. Edema
  4. Telangiectasis (Telangiectasia)
  5. Macular Edema
Show All >>

Key Therapies for Vision Disorders

Efficacy Chart >>
  1. Vitrectomy : 3 outcomes in 8 results
  2. Lenses : 1 outcome 1 study in 4 results
  3. Lasers (Laser) : 1 outcome in 4 results
  4. Light Coagulation : 1 outcome in 3 results
  5. Traction : 1 outcome in 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.